KALRAY/EASYMILE
6.1.2021 18:02:21 CET | Business Wire | Press release
Autonomous technology provider EasyMile and intelligent processors supplier Kalray have deepened their relationship with the signature of a Memorandum of Understanding (MoU) formalizing their relationship to develop intelligent systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210106005553/en/
The partnership follows their work together in the ten-partner-strong ES3CAP collaborative project, led by Kalray and announced in 2019. The ES3CAP program, with a budget of €22.2 million over 3 years, aims to build a hardware and software platform intended for manufacturers developing critical applications requiring high computing capacity in the fields of aeronautics (aviation, flying cabs, UAVs), defense and, autonomous vehicles.
EasyMile’s technology interacts with all kinds of next-generation radars, cameras, and lidar sensors to autonomize a range of vehicles. Its vehicle-agnostic software makes it the partner of choice for global Original Equipment Manufacturers (OEMs). As a fabless company, EasyMile develops autonomous vehicle solutions that tackle identified use-cases very precisely using common-core, unique technology. EasyMile’s solutions require underlying platforms providing both safety and performance.
Benoit Perrin, Managing Director of EasyMile : “Safety and performance reliability are key to embedded systems. This collaboration with Kalray, which started with the ES3CAP program, matches the high criteria we expect of our partners and we are delighted to be working with them .”
Eric Baissus, CEO of Kalray : ”EasyMile is one of the most advanced companies delivering safe solutions for autonomous vehicles. For us, this collaboration is further evidence of the value that our MPPA® intelligent processors and SuperECU® solution can bring to easily build safe autonomous systems .”
Autonomous vehicles require ECUs (“Electronic Computing Unit”) capable of running a multitude of applications in parallel with no compromise on safety. Kalray’s SuperECU®, based on Kalray MPPA® Intelligent Processor, is a patented platform capable of providing both the demanding performance required to compute functions such as artificial intelligence algorithms but also to support multi-applications with different levels of criticality on the same chip. Kalray’s MPPA® processor is one of the rare solutions on the market to ensure complete freedom from interference between these applications, which is a key attribute in building safe systems.
In addition, Kalray intelligent processors are not only capable of executing AI algorithms but can also simultaneously execute a wide set of different processing such as mathematical algorithms, signal processing and networking software stacks. This heterogenous multi-processing capability is also a critical requirement for autonomous vehicles, and is a unique capability of Coolidge™, 3rd generation of MPPA® processor available now.
ABOUT EASYMILE
EasyMile provides software and complete solutions for driverless mobility and goods transportation. EasyMile partners with manufacturers to autonomize their vehicles with award-winning technology built on safety-by-design, ready for deployment today.
Since 2014, Easymile has become known for quality delivery and real-world deployments. Its proven technology has driven autonomous vehicles in 300+ locations in more than 30 countries: The EZ10 is the most deployed autonomous shuttle in the world. For material handling, TractEasy is a tow-truck solution optimizing supply chains with cross/indoor-outdoor, 24/7 material handling at factories and industrial sites.
With several mass operations around the world EasyMile was the first to deploy fully driverless at Level 4 of autonomous driving. It was also the first autonomous vehicle solutions provider to be ISO 9001 certified. At the core of EasyMile's cutting-edge sofware is a step-by-step approach to safety proven by a zero-collision record. EasyMile's future-ready technology specializes in robotics, computer vision and vehicle dynamics powered by deep learning. Among its customers leading transport operators, city authorities, airports, business parks, manufatcurers, factories, logistics centers and universities.
Headquartered in Toulouse, France, the company employs close to 250 highly qualified employees. In addition to the two founders, Gilbert Gagnaire and Philippe Ligier, EasyMile has investors who are also technical partners: Alstom, Continental and Bpifrance. www.easymile.com
ABOUT KALRAY
Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is a fabless semiconductor company, leading provider in a new generation of processors specialized in Intelligent Data Processing from Cloud to Edge. Kalray MPPA® Intelligent Processors are able to capture and analyze on the fly massive data flows, and interact in real time with the outside world. These processors are capable of running demanding AI algorithms and simultaneously a wide set of different processing and control tasks such as intensive mathematical algorithms, signal processing, network or storage software stacks. Kalray’s Intelligent Processors can be deployed in fast-growing sectors from Cloud to Edge: modern data centers, 5G telecom networks, autonomous vehicles, healthcare equipment, industry 4.0, drones and robots… Kalray’s offering includes processors, acceleration cards and a software suite, for a broad spectrum of customers such as next generation data center equipment manufacturers and service providers, system integrators and consumer product manufacturers such as car makers. Founded in 2008 as a spin-off of CEA French lab, Kalray counts among its investors: Alliance Venture (Renault-Nissan-Mitsubishi), Safran, NXP Semiconductors, CEA and Bpifrance. Read more at: www.kalrayinc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005553/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom